News Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Continue Reading Previous Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical UpdateNext Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 NASH Data and Multiple Oral Abstracts at EASL’s International Liver Congress™ Related Stories News Buy International Homes at the Global Property Expo, Singapore News Dr. Wonder Clinic Celebrates Major Milestone in Global Oral Health Advocacy with New Prevention Program News my mimi Strengthens Menstrual Education with Enhanced Learning Platform News Interact Direct Holdings Limited Files Late Early Warning Report News Universal Digital Acquires 10 Bitcoin in First Treasury Allocation News Gorilla Provides Business Updates
